- Home
- PSTV vs HSDT Comparison
PSTV vs HSDT Comparison
Compare PSTV & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- HSDT
- Stock Information
- Founded
- PSTV 1996
- HSDT 2014
- Country
- PSTV United States
- HSDT United States
- Employees
- PSTV N/A
- HSDT N/A
- Industry
- PSTV Medical/Dental Instruments
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PSTV Health Care
- HSDT Health Care
- Exchange
- PSTV Nasdaq
- HSDT Nasdaq
- Market Cap
- PSTV 2.1M
- HSDT 1.7M
- IPO Year
- PSTV N/A
- HSDT N/A
- Fundamental
- Price
- PSTV $0.79
- HSDT $0.29
- Analyst Decision
- PSTV Strong Buy
- HSDT Hold
- Analyst Count
- PSTV 3
- HSDT 1
- Target Price
- PSTV $11.50
- HSDT N/A
- AVG Volume (30 Days)
- PSTV 3.8M
- HSDT 79.0K
- Earning Date
- PSTV 05-14-2025
- HSDT 05-12-2025
- Dividend Yield
- PSTV N/A
- HSDT N/A
- EPS Growth
- PSTV N/A
- HSDT N/A
- EPS
- PSTV N/A
- HSDT N/A
- Revenue
- PSTV $5,824,000.00
- HSDT $520,000.00
- Revenue This Year
- PSTV $13.26
- HSDT $0.04
- Revenue Next Year
- PSTV $24.59
- HSDT $75.10
- P/E Ratio
- PSTV N/A
- HSDT N/A
- Revenue Growth
- PSTV 18.54
- HSDT N/A
- 52 Week Low
- PSTV $0.24
- HSDT $0.26
- 52 Week High
- PSTV $2.67
- HSDT $4.69
- Technical
- Relative Strength Index (RSI)
- PSTV 47.37
- HSDT 35.85
- Support Level
- PSTV $0.61
- HSDT $0.26
- Resistance Level
- PSTV $1.22
- HSDT $0.30
- Average True Range (ATR)
- PSTV 0.13
- HSDT 0.03
- MACD
- PSTV 0.02
- HSDT 0.00
- Stochastic Oscillator
- PSTV 29.16
- HSDT 30.48
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.